Search results
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
Homenewshere.com· 11 hours agoFDA advisers recommended that the new COVID-19 boosters for fall target the Omicron variant, which...
FDA Rescinds Marketing Ban On Juul E-Cigarettes
Forbes· 1 day agoThe agency rescinded its marketing denial orders for the e-cigarette maker’s products after further review of information provided by Juul—as well as new...
The FDA reverses ban on Juul e-cigarettes
AOL· 13 hours agoThe Food and Drug Administration announced Thursday that it has reversed its ban on Juul e-cigarettes while it reviews new court decisions and considers updated information provided by the vape ...
US FDA Rescinds Market Denial Order for Juul Products
US News & World Report· 14 hours agoThe latest move comes a few months after Juul sought an FDA authorization for new menthol-flavored pods meant to be used with its e-cigarette device, which was under the agency's ...
US FDA rescinds market denial order for Juul products
AOL· 14 hours agoThe latest move comes a few months after Juul sought an FDA authorization for new menthol-flavored pods meant to be used with its e-cigarettes device, which was under the ...
FDA Panel OKs New COVID Vaccine for Fall | FOX 28 Spokane
FOX 28 Spokane· 17 hours agoFood and Drug Administration advisory panel on Wednesday recommended updating the formula for COVID...
FDA panel picks JN.1 subvariant for fall COVID vaccines
The Hill via Yahoo News· 1 day agoThe expert advisory panel for the Food and Drug Administration (FDA) unanimously voted Wednesday in...
FDA rescinds 2022 Juul ban, company to pursue marketing authorization
Investing.com· 1 day agoFDA rescinds 2022 Juul ban, company to pursue marketing authorization
FDA Rescinds Juul Ban, Opening Door for Federal Clearance
The Wall Street Journal· 14 hours agoThe agency hasn’t yet reached a final determination on whether they can stay on the U.S. market, but...
FDA analysis raises no major concerns about Eli Lilly Alzheimer's drug
KSL Salt Lake City· 1 day agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
